EUVIMED · CrossrefZeitschrift
Advanced Cancer Research
ISSN 3106-0382 · ELS Publishing Co. Limited
Neueste Artikel
An update on post-translational modifications of p53 from molecular mechanisms to therapeutic opportunities in cancer
Identification PDF as a biomarker of “cold” CRC using integrated bioinformatics and machine learning
Advanced Cancer Research: defining a platform for convergent oncology
Artificial intelligence in oncology drug discovery: from target identification to therapeutic molecule generation
Tumor microenvironment responsive nanotherapeutics in cancer treatment: obstacles, opportunities and future prospects
Post-translational modifications of KRAS: from molecular regulation to therapeutic targeting
EUVIMED